申请人:UPJOHN CO
公开号:WO2004039763A1
公开(公告)日:2004-05-13
The invention features quaternary ammonium compounds of formula I, described herein, and their use in treating asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious rhinitis.
该发明涉及式I所描述的季铵化合物,以及它们在治疗哮喘、慢性阻塞性肺病、过敏性鼻炎和感染性鼻炎中的应用。